GSK plc Rightofuse Assets Increase Decrease In Revaluation Surplus
GSK plc (GLAXF) reported Rightofuse Assets Increase Decrease In Revaluation Surplus of -GBP 2.00 million for the 12-month period ending 2020-12-31, per its 20-F filed 2022-03-08.
Discontinued › Notes
ifrs-full:RightofuseAssetsIncreaseDecreaseInRevaluationSurplus · last filed 2022-03-08
| Period end | Rightofuse Assets Increase Decrease In Revaluation Surplus 12 month |
|---|---|
| 2020-12-31 | -2.00M GBP 20-F · filed 2022-03-08 |